Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
NLSP NLS Pharmaceutics
- 1.9500
- -0.4300-18.07%
Close Dec 20 16:00 ET
- 1.9000
- -0.0500-2.56%
Post 20:01 ET
4.62MMarket Cap-0.29P/E (TTM)
2.2851High1.7800Low262.54KVolume2.2300Open2.3800Pre Close531.69KTurnover17.51%Turnover RatioLossP/E (Static)2.37MShares24.336052wk High-0.50P/B2.92MFloat Cap1.730052wk Low--Dividend TTM1.50MShs Float294.0000Historical High--Div YieldTTM21.22%Amplitude1.7300Historical Low2.0250Avg Price1Lot Size
NLS Pharmaceutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||||
| Cash flow from continuing operating activities | 30.22%-9.68M | 7.07%-13.88M | -1,947.76%-14.94M | -283.87%-729.39K | 93.05%-190.01K | 49.69%-2.73M | -5.43M |
| Net income from continuing operations | 26.21%-12.17M | -38.08%-16.5M | -317.49%-11.95M | 47.47%-2.86M | -5.84%-5.45M | 22.69%-5.15M | ---6.66M |
| Operating gains losses | 274.35%59.53K | -172.36%-34.14K | 134.92%47.18K | 0.00%20.09K | -24.40%20.09K | 54.58%26.57K | --17.19K |
| Depreciation and amortization | 0.00%11.41K | 13.51%11.41K | --10.05K | --0 | --0 | ---- | ---- |
| Other non cash items | ---- | 2,277.98%989.5K | -42.36%41.61K | -93.56%72.19K | -34.84%1.12M | 98.30%1.72M | --867.2K |
| Change In working capital | 38.41%2.25M | 151.38%1.63M | -255.24%-3.17M | -50.45%2.04M | 516.48%4.12M | 96.23%667.75K | --340.29K |
| -Change in receivables | --0 | --0 | -61.73%-21.8K | -1,448.20%-13.48K | 102.43%1K | -192.07%-41.1K | --44.64K |
| -Change in prepaid assets | -190.55%-632.13K | 469.46%698.12K | -5,334.40%-188.95K | 78.32%-3.48K | -317.26%-16.04K | 138.78%7.38K | ---19.03K |
| -Change in payables and accrued expense | 199.69%2.93M | 133.47%976.37K | -240.16%-2.92M | 27.55%2.08M | 132.60%1.63M | 122.92%701.47K | --314.68K |
| -Change in other current liabilities | 11.40%-42.24K | -22.51%-47.68K | -59.88%-38.92K | ---24.34K | ---- | ---- | ---- |
| -Change in other working capital | ---- | ---- | ---- | ---- | --2.5M | ---- | ---- |
| Cash from discontinued investing activities | |||||||
| Operating cash flow | 30.22%-9.68M | 7.07%-13.88M | -1,947.76%-14.94M | -283.87%-729.39K | 93.05%-190.01K | 49.69%-2.73M | ---5.43M |
| Investing cash flow | |||||||
| Cash flow from continuing investing activities | 0 | 0 | -39.56K | 0 | 0 | ||
| Net PPE purchase and sale | --0 | --0 | ---39.56K | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | |||||||
| Investing cash flow | --0 | --0 | ---39.56K | --0 | --0 | ---- | ---- |
| Financing cash flow | |||||||
| Cash flow from continuing financing activities | -90.61%1.63M | -14.46%17.4M | 3,939.12%20.34M | 23.57%503.52K | -26.96%407.48K | -91.71%557.92K | 6.73M |
| Net issuance payments of debt | 97.83%1.63M | 139.24%825.84K | -276.82%-2.1M | 78.26%1.19M | 19.67%667.69K | -83.83%557.92K | --3.45M |
| Net common stock issuance | --0 | -36.65%9.22M | --14.55M | --0 | --0 | ---- | --3.28M |
| Proceeds from stock option exercised by employees | --0 | -6.83%7.35M | --7.89M | --0 | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | -163.90%-686.7K | ---260.21K | ---- | ---- |
| Cash from discontinued financing activities | |||||||
| Financing cash flow | -90.61%1.63M | -14.46%17.4M | 3,939.12%20.34M | 23.57%503.52K | -26.96%407.48K | -91.71%557.92K | --6.73M |
| Net cash flow | |||||||
| Beginning cash position | 64.76%8.95M | 5,695.69%5.43M | -57.46%93.71K | 3,198.40%220.27K | -99.69%6.68K | 147.28%2.18M | --882.77K |
| Current changes in cash | -328.89%-8.05M | -34.41%3.52M | 2,474.10%5.36M | -203.86%-225.86K | 110.00%217.47K | -268.05%-2.17M | --1.29M |
| Effect of exchange rate changes | --0 | 99.60%-100 | -124.92%-24.74K | 2,658.83%99.31K | -183.49%-3.88K | -123.04%-1.37K | --5.94K |
| End cash Position | -89.97%897.68K | 64.76%8.95M | 5,695.69%5.43M | -57.46%93.71K | 3,198.40%220.27K | -99.69%6.68K | --2.18M |
| Free cash flow | 30.22%-9.68M | 7.32%-13.88M | -1,953.18%-14.98M | -283.87%-729.39K | 93.05%-190.01K | 49.69%-2.73M | ---5.43M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | -- |